LBA-1 The Phase III Study: Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC)
Titel:
LBA-1 The Phase III Study: Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC)
Auteur:
Pishvaian, M. Lopez, C. Zervos, E. Hatoum, H. Berg, D. Ucar, A. Boone, B. Johnson, T. Zureikat, A. Kenneth, M. Chung, K. Gandhi, R. Nazemzadeh, R. Parikh, N. Novelli, P. Kouri, B. Laing, C. Bates, S. Agah, R. Goodman, K.